The YAP1 gene helps cells sense when to grow, divide, or stop, which supports normal organ development, tissue repair, and cell survival. This gene plays an important role in early development, especially in the eyes. If you carry a harmful YAP1 variant, some tissues may not form as expected, and rare inherited conditions can include eye differences such as coloboma or smaller eyes. When the YAP1 gene is overly active, it may also help some cancers grow.
What is a gene?
Genes are segments of DNA that hold information your cells can use to make molecules or direct processes in the body. Some carry the instructions for building proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes occur, where they take place, and how strongly they run. Together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
YAP1Gene function
What if the gene works
The YAP1 gene helps control when cells grow, divide, and stop. It supports normal tissue development, repair, and organ size by carrying signals from outside the cell into the nucleus.
Risk
What if the gene does not work
Changes in the YAP1 gene can disrupt early eye formation, often causing coloboma or other eye differences; some people also have hearing loss or developmental differences. Milder and more severe variants can lead to different features and severity.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the YAP1 gene is currently established for people with a pathogenic variant in the YAP1 gene. The YAP1 gene is being studied as a drug target and biomarker in several cancers, but this has not led to guideline-based treatment choices for inherited YAP1-related conditions.
Conditions associated with YAP1
Gene function
What if the gene works
Cells need constant updates about when to grow, settle down, or help with repair. The YAP1 gene helps pass along these messages so growth stays coordinated with the needs of each tissue. This is part of how the YAP1 gene helps cells grow, repair, and stay organized in everyday life.
The YAP1 gene helps cells respond to signals that say when growth is needed. It supports balanced cell division during normal development and routine tissue upkeep.
The YAP1 gene does not usually switch genes on by itself. Its protein partners with other proteins to turn on groups of genes that support growth, repair, and cell survival.
YAP1 helps cells react to their surroundings, including how crowded, stretched, or firmly attached they are. This lets tissues adjust growth to fit the space and structure around them.
During normal wear and tear, YAP1 supports the renewal of cells that line and maintain tissues. It helps coordinate the steady replacement of older cells and an orderly repair response.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the YAP1 gene often weaken the protein or shorten it, so it may not reach the cell nucleus or bind partner proteins normally to control gene activity. How variants in the YAP1 gene affect function depends on the change: milder variants may leave some activity, while more disruptive variants can cause a greater loss of signaling. In people with conditions linked to the YAP1 gene, that greater loss is often linked to earlier eye development problems.
How variants are linked to conditions
Pathogenic variants in the YAP1 gene cause a rare developmental condition most often marked by ocular coloboma linked to the YAP1 gene, where part of the eye does not form completely. Some people also have unusually small eyes, hearing loss, cleft lip or palate, or differences in learning and development. Features vary widely, even within the same family.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a usual part of human biology. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a potential link, not a definite diagnosis, particularly when several genes and environmental influences also play a role. In certain situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the YAP1 gene. In most cases, any impact depends mainly on the exact gene change and the condition involved, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of YAP1 variants
YAP1-related conditions that have a well-established inheritance pattern are usually inherited in an autosomal dominant way. This means a person with a disease-causing variant in the YAP1 gene has a 50% chance of passing it on to each child, regardless of sex. In some families, the variant is inherited from an affected parent, while in other cases it can arise as a new de novo variant in the child. When people look up how YAP1 variants are inherited, this autosomal dominant pattern is the main one described for confirmed YAP1-related eye and developmental conditions.
What does my YAP1 result mean for my family?
For YAP1, the clearest family pattern is dominant for certain rare eye-development conditions, which means a parent, sibling, or child may also carry the same gene change and may want to discuss whether testing would be helpful for them. In some families the change is new in one person, so it is not always inherited from a parent. The exact family impact depends on the specific YAP1 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
YAP1 genetic testing usually uses a blood sample or saliva, and the lab reads the YAP1 gene to look for variants. Testing may examine only this gene or include it in a panel of several genes, and the results can show whether a variant is linked to a known condition, uncertain, or not clinically significant.
When should I consider getting a genetic test?
Genetic testing for the YAP1 gene may be worth considering when a baby or child has eye development changes present from birth, such as a gap in part of the eye, very small eyes, or a strong family history of similar findings. A YAP1 result can help confirm whether these changes are part of an inherited condition.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it explains varies by the condition and the type of variant involved. Over time, many other factors also affect how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the YAP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about side effects, treatment response, or new symptoms are best discussed with your doctor. YAP1 has been studied in cancer research because its activity may affect how some tumors respond to treatment, but this is not yet used routinely to choose or adjust medicines.
History
The YAP1 gene entered research in the mid 1990s, when scientists identified a protein that interacted with the YES1 signaling protein and named it yes associated protein. Initially understood only through visible traits, later recognized as tied to a specific gene, it soon became part of a larger effort to map how cells control growth. In the 2000s, studies in fruit flies and mammals linked YAP1 to the Hippo pathway, a major step in understanding how tissues regulate size and repair. From these first observations, research expanded steadily. YAP1 is now a familiar name in cancer biology and regenerative medicine because of its role in those landmark discoveries.